RT Journal Article
SR Electronic
T1 Maternal first trimester metabolic profile in TGA pregnancies - a case-control study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.11.22268842
DO 10.1101/2022.01.11.22268842
A1 Huida, Johanna
A1 Ojala, Tiina
A1 Hautala, Johanna
A1 Surcel, Heljä-Marja
A1 Priest, James R
A1 Helle, Emmi
YR 2022
UL http://medrxiv.org/content/early/2022/01/13/2022.01.11.22268842.abstract
AB Objective To evaluate the association between maternal first trimester metabolic profile and transposition of the great arteries (TGA) in the offspring.Design A matched case-control study using national register data and maternal first trimester blood samples.Settings FinlandPatients A total of 100 mothers with TGA in their offspring and 200 controls matched by the year of birth and sex of the child, and the age and the body mass index (BMI) of the mother.Interventions None.Main outcome measures To identify the impact of 73 metabolic measure concentrations on the likelihood that a child would be born with TGA.Results A higher concentration of four subtypes in extremely large very-low-density lipoprotein (VLDL) particles and one in large VLDL particles were observed in mothers with TGA in their offspring. This finding did not reach statistical significance after multiple testing correction. In the analysis of the subgroups of maternal BMI over 25 and 30 only, the odds ratios (OR) of the metabolic variables were higher compared to the original population. In the group with a BMI over 25 the mean OR was 1.3 (N= 111, total) and in the group with a BMI over 30 the mean OR was 2.1 (N= 42, total).Conclusions We found no statistically significant difference between the metabolic profiles of mothers with TGA in their offspring, and their controls. However, the trend in our BMI-matched study potentially indicates that the likelihood of TGA development associates with maternal early-pregnancy metabolic profile, and the association is more pronounced in the subgroups of BMI over 25 and 30. Further studies are needed especially in the higher BMI groups.What is already known on this topic?The most important structures of the heart develop during early pregnancy, but studies on the association of maternal metabolomics during the first trimester with CHD development are scarce.Maternal obesity and diabetes are known risk factors for CHD in the offspring but the precise developmental mechanisms underlying this risk remain unknown.What this study adds to this topic?The maternal metabolomic profile in early pregnancy is potentially associated with the likelihood of TGA development in the offspring.Metabolic markers in obese women may have a stronger association with the development of TGA but this connection requires further studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by grants from the Finnish Foundation for Pediatric Research, the Academy of Finland, the University of Helsinki, and the Pediatric Research Center of the Hospital District of Helsinki and Uusimaa (HUS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Helsinki University Hospital (HUS) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.